Phibro Animal Health Statistics
Total Valuation
PAHC has a market cap or net worth of $1.76 billion. The enterprise value is $2.45 billion.
| Market Cap | 1.76B | 
| Enterprise Value | 2.45B | 
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 | 
| Ex-Dividend Date | Sep 3, 2025 | 
Share Statistics
PAHC has 40.53 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 20.37M | 
| Shares Outstanding | 40.53M | 
| Shares Change (YoY) | +0.38% | 
| Shares Change (QoQ) | -0.02% | 
| Owned by Insiders (%) | 49.89% | 
| Owned by Institutions (%) | 52.20% | 
| Float | 20.20M | 
Valuation Ratios
The trailing PE ratio is 36.45 and the forward PE ratio is 16.48.
| PE Ratio | 36.45 | 
| Forward PE | 16.48 | 
| PS Ratio | 1.36 | 
| Forward PS | 1.18 | 
| PB Ratio | 6.15 | 
| P/TBV Ratio | 9.27 | 
| P/FCF Ratio | 42.02 | 
| P/OCF Ratio | 21.94 | 
| PEG Ratio | n/a | 
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.79, with an EV/FCF ratio of 58.58.
| EV / Earnings | 50.77 | 
| EV / Sales | 1.89 | 
| EV / EBITDA | 13.79 | 
| EV / EBIT | 18.35 | 
| EV / FCF | 58.58 | 
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 2.70.
| Current Ratio | 2.76 | 
| Quick Ratio | 1.04 | 
| Debt / Equity | 2.70 | 
| Debt / EBITDA | 4.03 | 
| Debt / FCF | 18.43 | 
| Interest Coverage | 3.79 | 
Financial Efficiency
Return on equity (ROE) is 17.80% and return on invested capital (ROIC) is 9.05%.
| Return on Equity (ROE) | 17.80% | 
| Return on Assets (ROA) | 7.13% | 
| Return on Invested Capital (ROIC) | 9.05% | 
| Return on Capital Employed (ROCE) | 12.51% | 
| Revenue Per Employee | $523,723 | 
| Profits Per Employee | $19,501 | 
| Employee Count | 2,475 | 
| Asset Turnover | 1.11 | 
| Inventory Turnover | 2.51 | 
Taxes
In the past 12 months, PAHC has paid $19.73 million in taxes.
| Income Tax | 19.73M | 
| Effective Tax Rate | 29.02% | 
Stock Price Statistics
The stock price has increased by +87.10% in the last 52 weeks. The beta is 0.82, so PAHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 | 
| 52-Week Price Change | +87.10% | 
| 50-Day Moving Average | 39.02 | 
| 200-Day Moving Average | 27.77 | 
| Relative Strength Index (RSI) | 67.15 | 
| Average Volume (20 Days) | 249,287 | 
Short Selling Information
The latest short interest is 966,217, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 966,217 | 
| Short Previous Month | 873,352 | 
| Short % of Shares Out | 2.38% | 
| Short % of Float | 4.78% | 
| Short Ratio (days to cover) | 3.65 | 
Income Statement
In the last 12 months, PAHC had revenue of $1.30 billion and earned $48.26 million in profits. Earnings per share was $1.19.
| Revenue | 1.30B | 
| Gross Profit | 405.62M | 
| Operating Income | 133.56M | 
| Pretax Income | 67.99M | 
| Net Income | 48.26M | 
| EBITDA | 177.75M | 
| EBIT | 133.56M | 
| Earnings Per Share (EPS) | $1.19 | 
Balance Sheet
The company has $78.48 million in cash and $770.91 million in debt, giving a net cash position of -$692.43 million or -$17.08 per share.
| Cash & Cash Equivalents | 78.48M | 
| Total Debt | 770.91M | 
| Net Cash | -692.43M | 
| Net Cash Per Share | -$17.08 | 
| Equity (Book Value) | 285.68M | 
| Book Value Per Share | 7.05 | 
| Working Capital | 517.13M | 
Cash Flow
In the last 12 months, operating cash flow was $80.12 million and capital expenditures -$38.29 million, giving a free cash flow of $41.83 million.
| Operating Cash Flow | 80.12M | 
| Capital Expenditures | -38.29M | 
| Free Cash Flow | 41.83M | 
| FCF Per Share | $1.03 | 
Margins
Gross margin is 31.29%, with operating and profit margins of 10.30% and 3.72%.
| Gross Margin | 31.29% | 
| Operating Margin | 10.30% | 
| Pretax Margin | 5.25% | 
| Profit Margin | 3.72% | 
| EBITDA Margin | 13.71% | 
| EBIT Margin | 10.30% | 
| FCF Margin | 3.23% | 
Dividends & Yields
This stock pays an annual dividend of $0.48, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | $0.48 | 
| Dividend Yield | 1.11% | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | 40.34% | 
| Buyback Yield | -0.38% | 
| Shareholder Yield | 0.73% | 
| Earnings Yield | 2.75% | 
| FCF Yield | 2.38% | 
Analyst Forecast
The average price target for PAHC is $27.50, which is -36.59% lower than the current price. The consensus rating is "Hold".
| Price Target | $27.50 | 
| Price Target Difference | -36.59% | 
| Analyst Consensus | Hold | 
| Analyst Count | 4 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
PAHC has an Altman Z-Score of 2.5 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.5 | 
| Piotroski F-Score | 6 |